HLN Haleon plc IFRS Annual reports only
Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1900304 · Reporting currency GBP · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: GBP | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 11.03B | 11.23B | 11.30B | 10.86B | 9.54B |
| Cost of revenue | 3.95B | 4.41B | 4.55B | 4.28B | 3.60B |
| Gross profit | 7.08B | 6.82B | 6.75B | 6.58B | 5.95B |
| R&D expense | 316.00M | 298.00M | 311.00M | 300.00M | 257.00M |
| SG&A expense | 4.36B | 4.45B | 4.41B | 4.48B | 4.09B |
| Operating income | 2.41B | 2.21B | 2.00B | 1.82B | 1.64B |
| Interest expense | 340.00M | 384.00M | 402.00M | 258.00M | 19.00M |
| Pretax income | 2.15B | 1.91B | 1.63B | 1.62B | 1.64B |
| Income tax | 472.00M | 435.00M | 517.00M | 499.00M | 197.00M |
| Net income | 1.67B | 1.44B | 1.05B | 1.06B | 1.39B |
| EBITDA | 2.77B | 2.53B | 2.31B | — | — |
| EPS (basic) | 0.19 | 0.16 | 0.11 | 0.12 | 0.15 |
| EPS (diluted) | 0.18 | 0.16 | 0.11 | 0.12 | 0.15 |
| Weighted avg. shares (diluted) | 9.03B | 9.18B | 9.26B | 9.24B | 9.23B |
| Balance sheet | |||||
| Cash & equivalents | 1.32B | 2.25B | 1.04B | 684.00M | 414.00M |
| Receivables | 2.06B | 2.06B | 1.86B | 1.88B | 2.21B |
| Inventory | 1.02B | 1.19B | 1.41B | 1.35B | 951.00M |
| Current assets | 4.55B | 5.72B | 4.82B | 4.06B | 5.25B |
| PP&E, netmay include right-of-use assets (IFRS) | 1.87B | 1.81B | 1.78B | 1.76B | 1.56B |
| Goodwill | 8.13B | 8.20B | 8.32B | 8.40B | 8.25B |
| Total assets | 32.63B | 34.31B | 34.05B | 34.81B | 34.45B |
| Current liabilities | 4.93B | 5.81B | 4.64B | 4.37B | 4.24B |
| Short-term debt | 836.00M | 1.49B | 656.00M | 437.00M | 79.00M |
| Long-term debt | 7.77B | 8.64B | 8.80B | 10.00B | 87.00M |
| Total debt | 8.61B | 10.13B | 9.46B | 10.44B | 166.00M |
| Total liabilities | 16.15B | 18.09B | 17.33B | 18.36B | 7.97B |
| Shareholders' equity | 16.43B | 16.17B | 16.61B | 16.33B | 26.36B |
| Net debt | 7.29B | 7.88B | 8.41B | 9.76B | -248.00M |
| Shares outstanding | 8.95B | 9.08B | 9.23B | — | — |
| Cash flow statement | |||||
| Operating cash flow | 2.63B | 2.30B | 2.10B | 2.06B | 1.36B |
| Capital expenditure | 322.00M | 250.00M | 234.00M | 304.00M | 228.00M |
| Free cash flow | 2.31B | 2.05B | 1.87B | 1.76B | 1.13B |
| Investing cash flow | -346.00M | 528.00M | -134.00M | -8.78B | -33.00M |
| Financing cash flow | -3.14B | -1.54B | -1.57B | 6.91B | -1.24B |
| Depreciation & amortization | 360.00M | 324.00M | 309.00M | — | — |
| Stock-based compensation | 86.00M | 102.00M | 76.00M | 15.00M | 59.00M |
| Dividends paid | 612.00M | 570.00M | 388.00M | 2.68B | 1.15B |
| Share buybacks | — | — | 38.00M | — | — |
Free plan shows the latest 5 periods; Pro shows all 6 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· Amounts are in the company's reporting currency, GBP, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.